FDA plans another safety study of abortion drug after court order
THE SO WHAT
Regulatory science is being dragged into a political trench war — if mifepristone can be forced into repeated “re-evaluation,” any high-profile therapeutic is exposed to the same tactic. Health operators should assume more volatility in label, access, and risk communication even for long-established drugs and build faster response muscle around legal-driven safety reviews, not just data-driven ones.
READ THE SOURCE
MORE FROM THE WIRE
Tech & InnovationRazer’s Wireless Gaming Earbuds Are Back With Upgraded ANC
Gaming peripherals are converging with mainstream audio—Razer is selling latency, ANC, and ecosystem lock-in, not just RGB. If you build around “PC gamer” as a niche, assume your user now expects Apple-level polish and cross-device continuity.
Tech & Innovation'I'm going to play this with my granddaughter' — Mark Hamill on Lego Smart Play and nearly 50 years of Star Wars
Lego Smart Play leans into connected, interactive sets wrapped in a 50-year IP—this is toy as software platform, not plastic. If you own a franchise or kids’ brand, your moat is longitudinal engagement across generations, not one-off merch drops.
I was put on a PIP at Amazon and took an offer to leave. I thought finding a new job would be easy — I was wrong.
A PIP at a marquee tech company is no longer a quick hop to a better role—this story is a reminder that the talent market has structurally repriced mid-level operators. If you’re on the market, treat geography, domain focus, and network as first-class levers, not afterthoughts.
Tech & InnovationThe Cassidy-Kaine proposal does virtually nothing to solve Social Security’s financial problems
If Social Security reform proposals dodge real revenue and benefit changes, long-term retirement risk is being pushed back onto employers and individuals by default. HR and finance leaders should assume higher demand for private retirement products and delayed retirements in workforce planning.